Abstract
We studied the effect of purified interleukin 2 (IL-2), made by recombinant DNA techniques, on the serum antibody response to myoglobin in high- and low-responder mice. Previous studies (6, 7) have shown that this response is controlled by H-2-linked Ir genes. The IL-2 was emulsified with the antigen in complete Freund's adjuvant to provide a sustained high local concentration. In low-responder B10.BR mice, a single dose (optimum 50,000 U) resulted in a consistent 10-50-fold increase in specific serum antibody throughout the time course of the response, from 10 d to 46 d after immunization. In contrast, no effect of IL-2 was seen in congenic high-responder B10.D2 mice. With IL-2, the low-responder mice achieved specific antibody levels comparable to those of high responders. Vehicle alone had no effect, and IL-2 alone, without antigen, did not induce myoglobin-specific antibody. No effect of IL-2 was seen in athymic nude mice of high-responder H-2 haplotype. The effect of IL-2 may be on a small number of responding T cells in the low responder mice, but it is possible that IL-2 also acts directly on B cells in a response that remains T-dependent, and therefore is not observed in athymic mice. We suggest that IL-2 may enhance suboptimal T cell help in the low responder, whereas help is not limiting in the high responder. This approach may enable the study of antibody responses in low responders otherwise too weak to analyze, and may be useful in producing antibodies to poorly immunogenic antigens. Potential clinical uses include immunization with weak antigens in normal patients, or with any antigen in certain immunodeficient patients.
Full Text
The Full Text of this article is available as a PDF (368.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Armerding D., Katz D. H. Activation of T and B lymphocytes in vitro. II. Biological and biochemical properties of an allogeneic effect factor (AEF) active in triggering specific B lymphocytes. J Exp Med. 1974 Jul 1;140(1):19–37. doi: 10.1084/jem.140.1.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Berzofsky J. A., Richman L. K., Killion D. J. Distinct H-2-linked Ir genes control both antibody and T cell responses to different determinants on the same antigen, myoglobin. Proc Natl Acad Sci U S A. 1979 Aug;76(8):4046–4050. doi: 10.1073/pnas.76.8.4046. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Donohue J. H., Rosenberg S. A. The fate of interleukin-2 after in vivo administration. J Immunol. 1983 May;130(5):2203–2208. [PubMed] [Google Scholar]
- Durum S. K., Higuchi C., Ron Y. Accessory cells and T cell activation. The relationship between two components of macrophage accessory cell function: I-A and IL1. Immunobiology. 1984 Dec;168(3-5):213–231. doi: 10.1016/S0171-2985(84)80112-6. [DOI] [PubMed] [Google Scholar]
- Kawamura H., Kohno Y., Busch M., Gurd F. R., Berzofsky J. A. A major anti-myoglobin idiotype. Influence of H-2-linked Ir genes on idiotype expression. J Exp Med. 1984 Sep 1;160(3):659–678. doi: 10.1084/jem.160.3.659. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kohno Y., Berzofsky J. A. Genetic control of immune response to myoglobin. Ir gene function in genetic restriction between T and B lymphocytes. J Exp Med. 1982 Nov 1;156(5):1486–1501. doi: 10.1084/jem.156.5.1486. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kohno Y., Berzofsky J. A. Genetic control of the immune response to myoglobin. V. Antibody production in vitro is macrophage and T cell-dependent and is under control of two determinant-specific Ir genes. J Immunol. 1982 Jun;128(6):2458–2464. [PubMed] [Google Scholar]
- Morgan D. A., Ruscetti F. W., Gallo R. Selective in vitro growth of T lymphocytes from normal human bone marrows. Science. 1976 Sep 10;193(4257):1007–1008. doi: 10.1126/science.181845. [DOI] [PubMed] [Google Scholar]
- Nakanishi K., Malek T. R., Smith K. A., Hamaoka T., Shevach E. M., Paul W. E. Both interleukin 2 and a second T cell-derived factor in EL-4 supernatant have activity as differentiation factors in IgM synthesis. J Exp Med. 1984 Dec 1;160(6):1605–1621. doi: 10.1084/jem.160.6.1605. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rosenberg S. A., Grimm E. A., McGrogan M., Doyle M., Kawasaki E., Koths K., Mark D. F. Biological activity of recombinant human interleukin-2 produced in Escherichia coli. Science. 1984 Mar 30;223(4643):1412–1414. doi: 10.1126/science.6367046. [DOI] [PubMed] [Google Scholar]
- Rosenberg S. A., Spiess P. J., Schwarz S. In vivo administration of Interleukin-2 enhances specific alloimmune responses. Transplantation. 1983 Jun;35(6):631–634. doi: 10.1097/00007890-198306000-00024. [DOI] [PubMed] [Google Scholar]
- Smith K. A. Interleukin 2. Annu Rev Immunol. 1984;2:319–333. doi: 10.1146/annurev.iy.02.040184.001535. [DOI] [PubMed] [Google Scholar]
- Stötter H., Rüde E., Wagner H. T cell factor (interleukin 2) allows in vivo induction of T helper cells against heterologous erythrocytes in athymic (nu/nu) mice. Eur J Immunol. 1980 Sep;10(9):719–722. doi: 10.1002/eji.1830100912. [DOI] [PubMed] [Google Scholar]
- Tsudo M., Uchiyama T., Uchino H. Expression of Tac antigen on activated normal human B cells. J Exp Med. 1984 Aug 1;160(2):612–617. doi: 10.1084/jem.160.2.612. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Waldmann T. A., Goldman C. K., Robb R. J., Depper J. M., Leonard W. J., Sharrow S. O., Bongiovanni K. F., Korsmeyer S. J., Greene W. C. Expression of interleukin 2 receptors on activated human B cells. J Exp Med. 1984 Nov 1;160(5):1450–1466. doi: 10.1084/jem.160.5.1450. [DOI] [PMC free article] [PubMed] [Google Scholar]